FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023156788> ?p ?o ?g. }

• W2023156788 endingPage "524" @default.
• W2023156788 startingPage "516" @default.
• W2023156788 abstract "High doses of lidocaine are administered to patients undergoing liposuction. Monoethylglycinexylidide, the active metabolite of lidocaine, is 80 to 90 percent as potent as lidocaine, and its relative toxicity is approximately that of lidocaine. Monoethylglycinexylidide has not previously been measured in studies on lidocaine in liposuction. The aims of this study were to characterize systemic exposure to lidocaine and monoethylglycinexylidide and to measure lidocaine and monoethylglycinexylidide levels within the tissues. Five female volunteers between the ages of 29 and 40 years underwent liposuction. Lidocaine (1577 to 2143 mg, corresponding to 19.9 to 27.6 mg/kg) was infiltrated during the procedure. Levels of lidocaine and monoethylglycinexylidide in blood and lipoaspirate were assessed perioperatively. Tissue lidocaine and monoethylglycinexylidide levels were measured postoperatively using a microdialysis technique in vivo. The peak (maximal) concentration of lidocaine plus monoethylglycinexylidide was 2.2 to 2.7 microg/ml. Time to peak lidocaine plus monoethylglycinexylidide was 8 to 28 hours after infiltration began. Absorbed lidocaine was estimated to be 911 to 1596 mg; therefore, 45 to 93 percent (mean, 64 percent) of the infiltrated dose was ultimately absorbed. Lipoaspirate analysis showed that 9.1 to 10.8 percent (mean, 9.7 percent) of the infiltrated dose was removed during the procedure. Tissue lidocaine levels below 5 microg/ml were demonstrated from 4 to 8 hours postoperatively. The peak lidocaine plus monoethylglycinexylidide concentration was within safe limits in this group of subjects. Time to peak lidocaine plus monoethylglycinexylidide signifies a delayed peak and therefore a longer period of potential lidocaine toxicity than was originally thought. Microdialysis results demonstrated that tissue lidocaine levels may be subtherapeutic within 4 to 8 hours of the procedure. Investigation into factors controlling the resorption of lidocaine during liposuction is warranted in an effort to improve the duration of effect. Furthermore, considering the active metabolite monoethylglycinexylidide, longitudinal studies are necessary to determine whether improving the side effect profile of lidocaine by reducing the dose administered during liposuction may be possible without decreasing the perioperative analgesic effect." @default.
• W2023156788 created "2016-06-24" @default.
• W2023156788 creator A5008906700 @default.
• W2023156788 creator A5023070517 @default.
• W2023156788 creator A5028284780 @default.
• W2023156788 creator A5029168415 @default.
• W2023156788 creator A5031863072 @default.
• W2023156788 creator A5055085283 @default.
• W2023156788 creator A5069028201 @default.
• W2023156788 creator A5080780455 @default.
• W2023156788 creator A5091426630 @default.
• W2023156788 date "2004-08-01" @default.
• W2023156788 modified "2023-09-24" @default.
• W2023156788 title "Pharmacokinetics and Safety of Lidocaine and Monoethylglycinexylidide in Liposuction: A Microdialysis Study" @default.
• W2023156788 cites W101861224 @default.
• W2023156788 cites W1967366932 @default.
• W2023156788 cites W1970408527 @default.
• W2023156788 cites W1988728180 @default.
• W2023156788 cites W1989822787 @default.
• W2023156788 cites W1994474366 @default.
• W2023156788 cites W2008093935 @default.
• W2023156788 cites W2015335217 @default.
• W2023156788 cites W2024085094 @default.
• W2023156788 cites W2028361182 @default.
• W2023156788 cites W2050858999 @default.
• W2023156788 cites W2055657831 @default.
• W2023156788 cites W2058285356 @default.
• W2023156788 cites W2071748354 @default.
• W2023156788 cites W2088010101 @default.
• W2023156788 cites W2090229996 @default.
• W2023156788 cites W2101287621 @default.
• W2023156788 cites W2128161188 @default.
• W2023156788 cites W2130602633 @default.
• W2023156788 cites W2133914533 @default.
• W2023156788 cites W2147781944 @default.
• W2023156788 cites W2319870730 @default.
• W2023156788 cites W2328911161 @default.
• W2023156788 cites W3173502537 @default.
• W2023156788 cites W4230990745 @default.
• W2023156788 cites W4238550514 @default.
• W2023156788 cites W4241144203 @default.
• W2023156788 cites W4252277473 @default.
• W2023156788 doi "https://doi.org/10.1097/01.prs.0000128423.84607.61" @default.
• W2023156788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15277825" @default.
• W2023156788 hasPublicationYear "2004" @default.
• W2023156788 type Work @default.
• W2023156788 sameAs 2023156788 @default.
• W2023156788 citedByCount "47" @default.
• W2023156788 countsByYear W20231567882012 @default.
• W2023156788 countsByYear W20231567882013 @default.
• W2023156788 countsByYear W20231567882014 @default.
• W2023156788 countsByYear W20231567882015 @default.
• W2023156788 countsByYear W20231567882017 @default.
• W2023156788 countsByYear W20231567882018 @default.
• W2023156788 countsByYear W20231567882019 @default.
• W2023156788 countsByYear W20231567882020 @default.
• W2023156788 countsByYear W20231567882021 @default.
• W2023156788 countsByYear W20231567882022 @default.
• W2023156788 crossrefType "journal-article" @default.
• W2023156788 hasAuthorship W2023156788A5008906700 @default.
• W2023156788 hasAuthorship W2023156788A5023070517 @default.
• W2023156788 hasAuthorship W2023156788A5028284780 @default.
• W2023156788 hasAuthorship W2023156788A5029168415 @default.
• W2023156788 hasAuthorship W2023156788A5031863072 @default.
• W2023156788 hasAuthorship W2023156788A5055085283 @default.
• W2023156788 hasAuthorship W2023156788A5069028201 @default.
• W2023156788 hasAuthorship W2023156788A5080780455 @default.
• W2023156788 hasAuthorship W2023156788A5091426630 @default.
• W2023156788 hasConcept C112705442 @default.
• W2023156788 hasConcept C126322002 @default.
• W2023156788 hasConcept C141071460 @default.
• W2023156788 hasConcept C2780140801 @default.
• W2023156788 hasConcept C2780149897 @default.
• W2023156788 hasConcept C42219234 @default.
• W2023156788 hasConcept C50156730 @default.
• W2023156788 hasConcept C529278444 @default.
• W2023156788 hasConcept C71924100 @default.
• W2023156788 hasConcept C98274493 @default.
• W2023156788 hasConceptScore W2023156788C112705442 @default.
• W2023156788 hasConceptScore W2023156788C126322002 @default.
• W2023156788 hasConceptScore W2023156788C141071460 @default.
• W2023156788 hasConceptScore W2023156788C2780140801 @default.
• W2023156788 hasConceptScore W2023156788C2780149897 @default.
• W2023156788 hasConceptScore W2023156788C42219234 @default.
• W2023156788 hasConceptScore W2023156788C50156730 @default.
• W2023156788 hasConceptScore W2023156788C529278444 @default.
• W2023156788 hasConceptScore W2023156788C71924100 @default.
• W2023156788 hasConceptScore W2023156788C98274493 @default.
• W2023156788 hasIssue "2" @default.
• W2023156788 hasLocation W20231567881 @default.
• W2023156788 hasLocation W20231567882 @default.
• W2023156788 hasOpenAccess W2023156788 @default.
• W2023156788 hasPrimaryLocation W20231567881 @default.
• W2023156788 hasRelatedWork W101861224 @default.
• W2023156788 hasRelatedWork W2013578574 @default.
• W2023156788 hasRelatedWork W2023156788 @default.
• W2023156788 hasRelatedWork W2052035531 @default.
• W2023156788 hasRelatedWork W2323602461 @default.

• next